To provide that the actuarial value of the prescription drug benefits of Members of Congress under the Federal employees health benefits program may not exceed the actuarial value of any prescription drug benefit under the Medicare Program.

Referred to the Subcommittee on Civil Service and Agency Organization.

Congressional Research Service

Official summary

Version 00 · Introduced in House · Jul 22, 2003

Prohibits the actuarial value of the prescription drug benefit afforded to a current or former Member of Congress under the the Federal Employees Health Benefits Program from exceeding the actuarial value of any prescription drug benefit which may become available under title XVIII (Medicare) of the Social Security Act if: (1) such member is eligible for such Medicare benefits; and (2) legislation providing for prescription drug benefits under Medicare is passed in the 1st session of the 108th Congress and enacted into law.

Read the summary on Congress.gov

PlainBill analysis is coming later. This page presents official source data. We have not yet published a PlainBill explanation for this bill.

People & committees

Who introduced it

Rep. Goode, Virgil H., Jr. [R-VA-5] · R–VA

Committees

Oversight and Government Reform Committee
Committee on House Administration

1 cosponsorship records, including any withdrawals

Rep. Davis, Tom [R-VA-11]

Legislative record

Actions

A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.

Aug 25, 2003
Referred to the Subcommittee on Civil Service and Agency Organization.
Jul 22, 2003
Referred to the Committee on House Administration, and in addition to the Committee on Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 22, 2003
Referred to the Committee on House Administration, and in addition to the Committee on Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 22, 2003
Referred to the Committee on House Administration, and in addition to the Committee on Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 22, 2003
Introduced in House
Jul 22, 2003
Introduced in House

Primary sources

Bill text & related measures

Text links open the official source. We currently store references to these documents.

Introduced in House · Jul 22, 2003 Formatted Text PDF

Related bills identified by Congress.gov

No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.

Source last updated: Apr 7, 2025. Consult Congress.gov for the current record.

AI Conversation Starters

Explore the bill from different angles

Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.

Neutral evidence review

Objective

Analyze H.R.2817 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.

View full prompt & sources

Discuss H.R.2817, 108th Congress: To provide that the actuarial value of the prescription drug benefits of Members of Congress under the Federal employees health benefits program may not exceed the actuarial value of any prescription drug benefit under the Medicare Program.

Official record: https://www.congress.gov/bill/108th-congress/house-bill/2817

Text version to examine: Introduced in House · 2003-07-22.

Official full text: https://www.congress.gov/108/bills/hr2817/BILLS-108hr2817ih.htm

Imported record last updated by the source: 2025-04-07T13:28:28Z. Verify current status and distinguish any later version from the version above.

Read the official text before answering. If you cannot access it, say so and ask me to provide it; do not assume a link means you have read the document. Distinguish proposals from enacted law, cite sources, and separate facts, interpretation, and uncertain predictions. Include counterarguments even when using a particular perspective.

Analyze H.R.2817 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.

Fairness and public impact

Progressive lens

Examine H.R.2817 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.

View full prompt & sources

Discuss H.R.2817, 108th Congress: To provide that the actuarial value of the prescription drug benefits of Members of Congress under the Federal employees health benefits program may not exceed the actuarial value of any prescription drug benefit under the Medicare Program.

Official record: https://www.congress.gov/bill/108th-congress/house-bill/2817

Text version to examine: Introduced in House · 2003-07-22.

Official full text: https://www.congress.gov/108/bills/hr2817/BILLS-108hr2817ih.htm

Imported record last updated by the source: 2025-04-07T13:28:28Z. Verify current status and distinguish any later version from the version above.

Read the official text before answering. If you cannot access it, say so and ask me to provide it; do not assume a link means you have read the document. Distinguish proposals from enacted law, cite sources, and separate facts, interpretation, and uncertain predictions. Include counterarguments even when using a particular perspective.

Examine H.R.2817 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.

Institutions and government scope

Conservative lens

Examine H.R.2817 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.

View full prompt & sources

Discuss H.R.2817, 108th Congress: To provide that the actuarial value of the prescription drug benefits of Members of Congress under the Federal employees health benefits program may not exceed the actuarial value of any prescription drug benefit under the Medicare Program.

Official record: https://www.congress.gov/bill/108th-congress/house-bill/2817

Text version to examine: Introduced in House · 2003-07-22.

Official full text: https://www.congress.gov/108/bills/hr2817/BILLS-108hr2817ih.htm

Imported record last updated by the source: 2025-04-07T13:28:28Z. Verify current status and distinguish any later version from the version above.

Read the official text before answering. If you cannot access it, say so and ask me to provide it; do not assume a link means you have read the document. Distinguish proposals from enacted law, cite sources, and separate facts, interpretation, and uncertain predictions. Include counterarguments even when using a particular perspective.

Examine H.R.2817 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.

Individual rights and government power

Liberty lens

Examine H.R.2817 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.

View full prompt & sources

Discuss H.R.2817, 108th Congress: To provide that the actuarial value of the prescription drug benefits of Members of Congress under the Federal employees health benefits program may not exceed the actuarial value of any prescription drug benefit under the Medicare Program.

Official record: https://www.congress.gov/bill/108th-congress/house-bill/2817

Text version to examine: Introduced in House · 2003-07-22.

Official full text: https://www.congress.gov/108/bills/hr2817/BILLS-108hr2817ih.htm

Imported record last updated by the source: 2025-04-07T13:28:28Z. Verify current status and distinguish any later version from the version above.

Read the official text before answering. If you cannot access it, say so and ask me to provide it; do not assume a link means you have read the document. Distinguish proposals from enacted law, cite sources, and separate facts, interpretation, and uncertain predictions. Include counterarguments even when using a particular perspective.

Examine H.R.2817 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.